文献速递外周动脉疾病

血管质量倡议中外周血管介入器械选择的噪声审计

Noise audit of device selection for peripheral vascular interventions in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2025-01-19

本研究对血管质量倡议(VQI)外周血管介入(PVI)登记数据库进行回顾性队列分析,构建8个临床场景和7个病变场景,评估相似患者和解剖条件下器械选择的变化。结果显示各场景中最常用器械的使用比例为32%至72%(临床场景)和34%至67%(病变场景),器械选择及特殊球囊使用在所有场景中差异显著(P < .0001)。结论认为PVI器械选择存在显著噪声,相似患者接受差异巨大的器械,需未来比较效果研究。

要点

  • 在15个模拟场景中,最常用器械使用比例仅为32%–72%,器械选择差异显著(P < .0001)。
  • 临床场景最常用器械使用32%–72%,病变场景为34%–67%。
  • 作者认为需未来比较效果研究以应对外周血管介入器械选择中的系统性噪声。

核心结论

  • 在15个模拟场景中,VQI中PVI器械选择及药物涂层球囊使用的噪声显著,相似血管病变患者接受差异巨大的器械。
  • 作者认为需未来比较效果研究以更有效应对外周血管介入器械选择中的系统性噪声。

研究设计与样本

  • 回顾性队列研究分析VQI PVI登记数据库,纳入2010年12月至2021年12月所有因跛行或慢性肢体威胁性缺血行PVI的患者。
  • 构建8个基于临床的场景和7个基于病变的场景,以最常用器械为参照标准量化每个模拟场景的变异性。

主要发现

  • 各模拟场景匹配患者数在临床场景为223至1379例,在病变场景为6166至26241例。
  • 临床场景中最常用器械使用比例为32%至72%,病变场景为34%至67%。
  • 所有患者场景中器械选择及特殊球囊使用的差异均显著(P < .0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a noise audit of the Vascular Quality Initiative (VQI) Peripheral Vascular Intervention (PVI) Registry to analyze variation in device selection for similar patients and anatomies. METHODS: We conducted a retrospective cohort study analysis of the VQI PVI Registry. Eight clinical-based and seven lesion-based scenarios were developed, and the VQI was queried for all procedures matching these descriptions from December 2010 to December 2021. All patients undergoing PVI for either claudication or chronic limb-threatening ischemia were included. Device selection was then identified for each procedure, with a treatment hierarchy to designate the primary device class along with a separate accounting of specialty balloons, including drug-coated and lithoplasty devices. Variability was then quantified in each mock patient scenario using the most commonly used device as the reference standard. RESULTS: The number of patients matching the criteria for each mock scenario ranged from 223 to 1379 across 8 clinical and from 6166 to 26,241 in 7 lesion-based scenarios. The most commonly used device in a given patient scenario was used between 32% and 72% of procedures in the clinical based scenarios, and between 34% and 67% of procedures in the lesion-based scenarios. Variation in device selection and use of specialty balloons were found to be significant across all patient scenarios (P < .0001). CONCLUSIONS: Noise in PVI device selection and use of drug-coated balloons in the VQI was significant across 15 mock scenarios. This finding indicates that similar patients with similar vascular pathologies are receiving vastly different devices and confirms that future comparative effectiveness studies are required to combat this systemic source of noise in device selection more effectively.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Robinson WK, Callas PW, Eldrup-Jorgensen J, et al. Noise audit of device selection for peripheral vascular interventions in the Vascular Quality Initiative. J Vasc Surg. 2025. PMID: 39837357. doi:10.1016/j.jvs.2025.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。